Brienne Kugler

Direttore Tecnico/Scientifico/R&S presso ROYALTY PHARMA PLC

Finance

Health Technology

Profilo

Ms. Brienne Kugler is an Analyst at Morgan Stanley & Co. LLC.
Ms. Kugler received her undergraduate degree from the Massachusetts Institute of Technology.

Posizioni attive di Brienne Kugler

Società	Posizione	Inizio
ROYALTY PHARMA PLC	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Brienne Kugler

Precedenti posizioni note di Brienne Kugler

Società	Posizione	Fine
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.	Analyst-Equity	-

Vedi nel dettaglio l'esperienza di Brienne Kugler

Formazione di Brienne Kugler

Massachusetts Institute of Technology

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Brienne Kugler

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ROYALTY PHARMA PLC	Health Technology

Aziende private	1
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.	Finance